Prognostic value of neutrophil to lymphocyte ratio and platelet counts during chemotherapy in patients with advanced gastric cancer

被引:0
|
作者
Li, Bo [1 ]
Wang, Kemeng [3 ]
Shi, Shuai [9 ]
Li, Meng [6 ]
Ma, Min-Ting [2 ]
Zhou, Zhi-Guo
Wang, Zhi-Cong [7 ]
Gong, Ya-Ning [5 ]
Xiao, Yajie [8 ]
Zhao, Liyan
Meng, Qingju [4 ]
Liu, Yi-Bing [2 ,10 ]
机构
[1] Hebei Med Univ, Hosp 4, Dept Radiol, Shijiazhuang, Peoples R China
[2] Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Peoples R China
[3] first affiliated Hosp, Xingtai Med Coll, Dept Internal Med, Bengbu, Peoples R China
[4] first affiliated Hosp, Xingtai Med Coll, Dept Orthoped, Bengbu, Peoples R China
[5] first affiliated Hosp, Xingtai Med Coll, Dept Med Oncol, Bengbu, Peoples R China
[6] Quyang Canc Hosp, Hengzhou Hosp, Dept Med Oncol, Zhengzhou, Peoples R China
[7] Cangzhou Cent Hosp, Dept Radiotherapy, Cangzhou, Hebei, Peoples R China
[8] YuceBio Technol Co Ltd, Shenzhen, Guangdong, Peoples R China
[9] Maastricht Univ, GROW, Sch Oncol & Dev Biol, Dept Pathol, Maastricht, Netherlands
[10] Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China
关键词
neutrophils; lymphocytes; platelets (PLTs); stomach neoplasms; chemotherapy; IMMUNE CELLS; INFLAMMATION; TUMORS; MARKER;
D O I
10.15537/smj.2023.44.11.20220946
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To investigate the predictive significance of dynamic changes in the neutrophil to lymphocyte ratio (NLR) and platelet counts (PLTs) in patients with advanced gastric cancer (GC) during chemotherapy. Methods: A total of 259 advanced GC patients receiving chemotherapy were enrolled and grouped by high or low NLR with a cut value of 2.5 and PLT with cut value of 300x109/L. The Kaplan-Meier survival model and the Log-rank test were carried out to determine the comparison on the overall survival differences. Cox regression analysis was employed to carry out both univariate and multivariate regression studies, aiming to explore potential prognostic factors acting independently. Results: Higher pre-chemotherapy NLR exhibited an association with metastasis and advanced grade of Borrmann type, and higher NLR of pre-or post chemotherapy GC patients was related with Borrmann type grade. Moreover, higher PLT counts are associated with advanced grades of Borrmann type. Interestingly, patients with lower post-chemotherapy NLR or decreasing NLR hold better overall response rate and disease control rate than those with higher NLR or increasing NLR. Furthermore, patients with high post chemotherapy NLR alone or higher post-chemotherapy NLR plus higher post-chemotherapy PLT. Conclusion: Our study suggested that high post chemotherapy NLR and post-chemotherapy PLT might be adverse prognostic markers in advanced GC patients undergoing chemotherapy.
引用
收藏
页码:1104 / 1112
页数:9
相关论文
共 50 条
  • [1] Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy
    Lee, Suee
    Oh, Sung Yong
    Kim, Sung Hyun
    Lee, Ji Hyun
    Kim, Min Chan
    Kim, Ki Han
    Kim, Hyo-Jin
    BMC CANCER, 2013, 13
  • [2] Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy
    Suee Lee
    Sung Yong Oh
    Sung Hyun Kim
    Ji Hyun Lee
    Min Chan Kim
    Ki Han Kim
    Hyo-Jin Kim
    BMC Cancer, 13
  • [3] The diagnostic and prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on gastric cancer patients
    Nguyen, Mai Ly Thi
    Pham, Chi
    Le, Quoc Vuong
    Nham, Phuong Linh Thi
    Tran, Doanh Hieu
    Le, Thanh Son
    Hoang, Van Tong
    Can, Van Mao
    Nguyen, Linh Toan
    Bui, Khac Cuong
    MEDICINE, 2023, 102 (31) : E34357
  • [4] Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer
    Zhang, Yan
    Lu, Jing-Jing
    Du, Yi-Ping
    Feng, Chun-Xia
    Wang, Li-Qiang
    Chen, Min-Bin
    MEDICINE, 2018, 97 (12)
  • [5] The analysis of the prognostic value of the neutrophil/lymphocyte ratio and the platelet/lymphocyte ratio among advanced endometrial cancer patients
    Muzykiewicz, Konrad Piotr
    Iwanska, Ewa
    Janeczek, Maja
    Glanowska, Izabela
    Karolewski, Kaziemierz
    Blecharz, Pawel
    GINEKOLOGIA POLSKA, 2021, 92 (01) : 16 - 23
  • [6] Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
    Wang, Huan
    Ding, Yongfeng
    Li, Ning
    Wu, Luntao
    Gao, Yuan
    Xiao, Cheng
    Jiang, Haiping
    Zheng, Yulong
    Mao, Chenyu
    Deng, Jing
    Wang, Haiyong
    Xu, Nong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [7] Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy.
    Kang, Seok Yun
    Choi, Yong Won
    Ahn, Mi Sun
    Lee, Hyun Woo
    Choi, Jin-Hyuk
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Prognostic value of neutrophil to lymphocyte ratio for gastric cancer
    Hu, Zhi-De
    Huang, Yuan-Lan
    Qin, Bao-Dong
    Tang, Qing-Qin
    Yang, Min
    Ma, Ning
    Fu, Hai-Tao
    Wei, Ting-Ting
    Zhong, Ren-Qian
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (04)
  • [9] Prognostic value of combined platelet, fibrinogen, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with lung adenosquamous cancer
    Wang, Yu-Qian
    Zhi, Qiong-Jie
    Wang, Xin-Yue
    Yue, Dong-Sheng
    Li, Kai
    Jiang, Ri-Cheng
    ONCOLOGY LETTERS, 2017, 14 (04) : 4331 - 4338
  • [10] Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer
    Hirahara, Tetsushi
    Arigami, Takaaki
    Yanagita, Shigehiro
    Matsushita, Daisuke
    Uchikado, Yasuto
    Kita, Yoshiaki
    Mori, Shinichiro
    Sasaki, Ken
    Omoto, Itaru
    Kurahara, Hiroshi
    Maemura, Kosei
    Okubo, Keishi
    Uenosono, Yoshikazu
    Ishigami, Sumiya
    Natsugoe, Shoji
    BMC CANCER, 2019, 19 (1)